相关实验视频
Updated: Mar 11, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
25.3K
[对患有先天性心脏缺陷的成年人进行设备治疗]
Adrian Reinhardt1, Götz Buchwalsky2, Leon Iden3
1Elektrophysiologie Bremen, Herzzentrum Bremen am Klinikum Links der Weser, Senator-Wessling-Strasse 1, 28277, Bremen, Deutschland. a.reinhardt@ep-bremen.de.
Herzschrittmachertherapie & Elektrophysiologie
|March 9, 2026
概括
在患有先天性心脏缺陷的患者中植入心脏器件是具有挑战性的,因为复杂的解剖学. 本综述为在这些复杂的病例中成功安装起器或除器提供了一份实用指南.
科学领域:
- 心脏病学 心脏病学
- 遗传性心脏病是一种先天性心脏病.
- 医疗器械植入 医疗器械植入
背景情况:
- 在患有先天性心脏缺陷的患者中,心脏植入器程序存在重大解剖学挑战.
- 这些程序需要专门的跨学科团队仔细规划和执行.
- 对复杂的先天性心脏病有经验的中心对于成功的结果至关重要.
研究的目的:
- 为在患有复杂先天性心脏缺陷的患者中进行起器或除器植入提供实用指南.
- 概述在设备植入期间管理解剖学复杂性的策略.
- 基于代表性的案例示例分享见解.
主要方法:
- 审查现有的文献和临床指南.
- 在复杂的先天性心脏缺陷中植入起器和除器的代表案例研究的分析.
- 强调跨学科的团队协作和专业的中心协议.
主要成果:
- 通过仔细的规划和量身定制的方法,可以实现成功的植入.
- 复杂解剖学的管理需要特定的技术和仔细的设备选择.
- 跨学科的合作是减轻风险和优化患者护理的关键.
结论:
- 在复杂的先天性心脏缺陷中,可以成功地进行起器和除器植入.
- 一种实用,以案例为基础的方法引导在这个具有挑战性的群体中成功植入设备.
- 专业中心和跨学科团队对于最佳的患者治疗结果至关重要.
相关概念视频
Heart Failure VI: Adjunct Therapies
494
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
494
Cardiomyopathy V: Interprofessional Care
566
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
566
Cardiomyopathy II: Dilated Cardiomyopathy
695
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
695
Rheumatic Heart Disease III: Medical Management
445
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
445
Cardiomyopathy III: Hypertrophic Cardiomyopathy
603
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
603
Mitral Stenosis III: Medical Management
404
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
404

